Financial Data and Key Metrics - Consolidated net revenue for Q1 2024 was 1.114billion,downfrom1.582 million in Q1 2023 [50] - Consolidated gross profit increased to 60.2% from 59.5% due to product mix of sales [50] - Operating loss was 1.226billioncomparedto1.188 million in the prior year [80] - Net loss was 1.310millionor0.07 per share, compared to 1.187millionor0.06 per share [80] - Cash and cash equivalents stood at 1.1millionasofMarch31,2024[68]BusinessLineDataandKeyMetrics−iHPservicerevenueincreasedby21250,000 in annual solution revenue starting Q4 2024 [45] - The company anticipates 600,000inBITsolutionrevenuefromcurrentCESinstallations[53]−AnewcontractwithaCalifornia−basedlifesciencescompanyforaSteraMistiHP−CESvaluedat600,000 was secured in February [69] Market Data and Key Metrics - The company is exploring opportunities in the biofuel industry, leveraging iHP technology for cellulose conversion [31] - SteraMist technology is being marketed for decontamination in data centers, a sector expected to see 1trillionininfrastructurespendingoverthenextfiveyears[32][7]−Thecompanyisexpandingitspresenceinthefoodsafetymarket,withsignificantinterestindecontaminationapplications[22][77]CompanyStrategyandIndustryCompetition−ThecompanyisfocusedonclosingmoreCESsales,drivingSIStraction,andexpandingiHPCorporateServicerevenues[82]−SignificantadvancementshavebeenmadewithfourdistinctmanufacturingcompaniesforSISproducts[34]−ThecompanyisdevelopinganeducationalplatformforitsTOMIservicenetworktoenhanceroutinedisinfectionpractices[27]ManagementCommentaryonOperatingEnvironmentandFutureOutlook−ManagementexpectssequentialgrowthandreducedlossesinQ22024,aimingforprofitabilitybyQ32024[62]−Thecompanyisactivelypursuingopportunitiesinmultipleverticals,includinglifesciences,pharmaceuticals,anddatacenters[31][32]−TheSteraMistProcertifiedprogramaimstosetindustrybenchmarksfordisinfectionandbiohazardresponse[28][29]OtherImportantInformation−Thecompanyreceiveda2 million allocation from the Department of Homeland Security for 16 SteraMist systems to decontaminate Plum Island, with revenue recognition expected in Q4 2024 [10][64] - A 3 million grant application was submitted to the Department of Defense for mitigating ethylene oxide sterilization [65] - The company is investigating fentanyl testing and has ongoing research with the USDA on food safety and pathogen kill [6][72] Q&A Session Summary Question: Timeline for revenue recognition from the 2 million DHS contract - Revenue recognition is expected in Q4 2024, with decontamination activities scheduled for Q1 or Q2 2025 [10] Question: Growth in the CES business and its impact on the razor/razorblade model - CES customers are consistent users of high-margin BIT solutions, with a strong pipeline in life sciences and pharmaceuticals [12] Question: Current cash position and path to profitability - The current cash position might support profitability, but additional funding is needed to scale the company and capitalize on opportunities [15] Question: Potential government stockpiling of SteraMist for emergency purposes - No specific plans for stockpiling, but the company continues research with the USDA on targeted areas [72] Question: Role of SteraMist in PFOS and PFOA treatment - The company is exploring applications but is limited by its size and focus on multiple verticals [84] Question: Interest in using SteraMist for bird flu prevention - The company is marketing its product for avian flu control, potentially preventing mass culling of birds [1][78]